Cargando…

Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort

OBJECTIVE: Elevated tumour necrosis factor (TNF)-α has been implicated in the progression of liver fibrosis and pathogenesis of non-alcoholic fatty liver disease (NAFLD). We aim to investigate the impact of anti-TNF-α agents on the development of cirrhosis and NAFLD. DESIGN: This retrospective cohor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Kuo-Tung, Dufour, Jean-François, Chen, Po-Hung, Hernaez, Ruben, Hutfless, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199652/ https://www.ncbi.nlm.nih.gov/pubmed/32377366 http://dx.doi.org/10.1136/bmjgast-2019-000349

Ejemplares similares

Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Mercer, Louise K, et al.
Publicado: (2017)

Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
por: Koralegedara, Iresha Sandamali, et al.
Publicado: (2022)

Physical activity and risk of fatty liver in people with different levels of alcohol consumption: a prospective cohort study
por: Tsunoda, Kenji, et al.
Publicado: (2014)

Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study
por: Hamaguchi, Masahide, et al.
Publicado: (2020)

Dietary patterns and risk of non-alcoholic fatty liver disease in Korean adults: a prospective cohort study
por: Fu, Jialei, et al.
Publicado: (2023)

Immunosuppression with Antitumour Necrosis Factor Therapy Leading to Strongyloides Hyperinfection Syndrome
por: Khaliq, Muhammad Farhan, et al.
Publicado: (2018)

Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM
por: Hayward, Kelly Lee, et al.
Publicado: (2021)

Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES III
por: Carrillo-Larco, Rodrigo M, et al.
Publicado: (2022)

Phase I trials of antitumour agents: fundamental concepts
por: Toloi, Diego de Araujo, et al.
Publicado: (2015)

Risk of liver cancer among US male veterans with cirrhosis, 1969–1996
por: Persson, E C, et al.
Publicado: (2012)

Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study
por: Nakajima, Kei, et al.
Publicado: (2013)

Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population
por: Zhang, Yongyuan, et al.
Publicado: (2015)

Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study
por: Ge, Xiaojun, et al.
Publicado: (2020)

ANTIMICROBIAL AGENTS IN THE PREVENTION OF DIETARY HEPATIC INJURY (NECROSIS, CIRRHOSIS) IN RATS
por: György, Paul, et al.
Publicado: (1951)

Trends of hospitalisation for patients with liver cirrhosis in Ningxia, China: a cross-sectional study
por: Shi, Chao, et al.
Publicado: (2023)

How much could a low COVID-19 pandemic change the injury trends? A single-institute, retrospective cohort study
por: Kuo, Ling-Wei, et al.
Publicado: (2021)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
por: Finckh, A, et al.
Publicado: (2020)

Association between nut intake and non-alcoholic fatty liver disease risk: a retrospective case-control study in a sample of Chinese Han adults
por: Chen, Bing bing, et al.
Publicado: (2019)

Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies
por: Chen, Ta-Liang, et al.
Publicado: (2017)

DNA stretching in the nucleosome facilitates alkylation by an intercalating antitumour agent
por: Davey, Gabriela E., et al.
Publicado: (2010)

Impact of universal health coverage on urban–rural inequity in psychiatric service utilisation for patients with first admission for psychosis: a 10-year nationwide population-based study in Taiwan
por: Chiang, Chih-Lin, et al.
Publicado: (2016)

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies
por: Hayward, Kelly L, et al.
Publicado: (2020)

Is insomnia a risk factor for new-onset asthma? A population-based study in Taiwan
por: Lin, Yu-Chieh, et al.
Publicado: (2017)

The association between a non-invasive hepatic fibrosis score and urolithiasis among non-alcoholic fatty liver disease (NAFLD) patients in China: a cross-sectional study
por: Qin, Shaoyou, et al.
Publicado: (2019)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
por: Koralegedara, Iresha Sandamali, et al.
Publicado: (2022)

Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003–2018): cross-sectional study
por: Li, Qianwen, et al.
Publicado: (2022)

Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register
por: Zimmermann, Esther, et al.
Publicado: (2015)

Interaction between alcohol dehydrogenase II gene, alcohol consumption, and risk for breast cancer
por: Stürmer, T, et al.
Publicado: (2002)

Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer
por: Taylor, Sarah J, et al.
Publicado: (2020)

Association between alcohol consumption/alcohol use disorders and patient complexity: a cross-sectional study
por: Sugiyama, Yoshifumi, et al.
Publicado: (2020)

Alcohol Consumption Among Young Adults Ages 18–24 in the United States: Results from the 2001–2002 NESARC Survey
por: Chen, Chiung M., et al.
Publicado: (2004)

Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohort
por: Fisher, Anat, et al.
Publicado: (2014)

Association between haemorrhoids and Graves’ disease: a retrospective cohort study using data from Taiwan’s Longitudinal Health Insurance Database
por: Zhong, Shang-Rong, et al.
Publicado: (2021)

Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: systematic review and metaregression
por: Slade, Tim, et al.
Publicado: (2016)

Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis
por: Skladany, Lubomir, et al.
Publicado: (2021)

Childhood adversities and adult-onset asthma: a cohort study
por: Korkeila, Jyrki, et al.
Publicado: (2012)

Impact of neighbourhood walkability on the onset of multimorbidity: a cohort study
por: Moin, John Sina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_40c719cvc617fom6j7i19sqba7